| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 6 523-531, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
A Polotskaya, Y Zhao, ML Lilly and AS Kraft
Division of Hematology/Oncology, University of Alabama, Birmingham 35294.
The human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor is composed of an alpha subunit which binds GM-CSF and a beta subunit which allows for high affinity binding. To investigate the role of the short cytoplasmic tail (54 amino acids) of the alpha receptor in mediating signal transduction and in controlling cell growth, we placed a stop codon after the alpha receptor transmembrane domain and expressed this receptor in murine Ba/F3 cells. Unlike the complete alpha subunit, this shortened receptor was unable to stimulate protein phosphorylation or mediate entry into the cell cycle. By comparing Ba/F3 cells expressing the alpha and beta receptors with those expressing the alpha or the terminated alpha receptor, we have been able to correlate specific GM-CSF-induced events with cell cycle commitment. We find that cell growth is correlated with prolonged increases in the cell levels of c-myc, pim-1, and cyclin D2 mRNAs, but not with changes in either immediate early genes or mitogen-activated protein kinase phosphorylation. This suggests that additional signal transduction pathways not mediated by known phosphoproteins are activated by GM-CSF. Since the beta receptor is shared by human interleukins 3 and 5, our data suggest that the specificity of response to GM-CSF is mediated in part by the short cytoplasmic tail of the alpha receptor subunit.
This article has been cited by other articles:
![]() |
K. J. Peltola, K. Paukku, T. L. T. Aho, M. Ruuska, O. Silvennoinen, and P. J. Koskinen Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3 Blood, May 15, 2004; 103(10): 3744 - 3750. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dhar-Mascareno, J. Chen, R. H. Zhang, J. M. Carcamo, and D. W. Golde Granulocyte-Macrophage Colony-stimulating Factor Signals for Increased Glucose Transport via Phosphatidylinositol 3-Kinase- and Hydrogen Peroxide-dependent Mechanisms J. Biol. Chem., March 21, 2003; 278(13): 11107 - 11114. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Evans, S. Ariffin, A. Pierce, and A. D. Whetton Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors Blood, October 16, 2002; 100(9): 3164 - 3174. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Goodman, P. Stricker, M. Velavicius, R. Fonseca, E. Kleinstein, R. Lavery, E. A. Deitch, C. J. Hauser, and H. H. Simms Role of Granulocyte-Macrophage Colony-Stimulating Factor and Its Receptor in the Genesis of Acute Respiratory Distress Syndrome Through an Effect on Neutrophil Apoptosis Arch Surg, October 1, 1999; 134(10): 1049 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Jenkins, F. Le, and T. J. Gonda A Cell Type-specific Constitutive Point Mutant of the Common beta -Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF), Interleukin (IL)-3, and IL-5 Receptors Requires the GM-CSF Receptor alpha -Subunit for Activation J. Biol. Chem., March 26, 1999; 274(13): 8669 - 8677. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Al-Shami and P. H. Naccache Granulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils. INVOLVEMENT OF Jak2 IN THE STIMULATION OF PHOSPHATIDYLINOSITOL 3-KINASE J. Biol. Chem., February 26, 1999; 274(9): 5333 - 5338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Frankel, M. Lilly, R. Kreitman, D. Hogge, M. Beran, M. H. Freedman, P. D. Emanuel, C. McLain, P. Hall, E. Tagge, et al. Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Is Toxic to Blasts From Patients With Juvenile Myelomonocytic Leukemia and Chronic Myelomonocytic Leukemia Blood, December 1, 1998; 92(11): 4279 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bankers-Fulbright, G. M. Kephart, D. A. Loegering, A. L. Bradford, S. Okada, H. Kita, and G. J. Gleich Sulfonylureas Inhibit Cytokine-Induced Eosinophil Survival and Activation J. Immunol., June 1, 1998; 160(11): 5546 - 5553. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Rivas, J. Carlos Vera, F. Delgado-Lopez, M. L. Heaney, V. H. Guaiquil, R. H. Zhang, H. I. Scher, I. I. Concha, F. Nualart, C. Cordon-Cardo, et al. Expression of Granulocyte-Macrophage Colony-Stimulating Factor Receptors in Human Prostate Cancer Blood, February 1, 1998; 91(3): 1037 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Al-Shami, W. Mahanna, and P. H. Naccache Granulocyte-Macrophage Colony-stimulating Factor-activated Signaling Pathways in Human Neutrophils. SELECTIVE ACTIVATION OF Jak2, Stat3, AND Stat5B J. Biol. Chem., January 9, 1998; 273(2): 1058 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuguchi, Y. Zhao, M. B. Lilly, and A. S. Kraft The Cytoplasmic Domain of Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Receptor alpha Subunit Is Essential for Both GM-CSF-mediated Growth and Differentiation J. Biol. Chem., July 11, 1997; 272(28): 17450 - 17459. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sakai and A. S. Kraft The Kinase Domain of Jak2 Mediates Induction of Bcl-2 and Delays Cell Death in Hematopoietic Cells J. Biol. Chem., May 9, 1997; 272(19): 12350 - 12358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Palaty, G. Kalmar, G. Tai, S. Oh, L. Amankawa, M. Affolter, R. Aebersold, and S. L. Pelech Identification of the Autophosphorylation Sites of the Xenopus laevis Pim-1 Proto-oncogene-encoded Protein Kinase J. Biol. Chem., April 18, 1997; 272(16): 10514 - 10521. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, P. Loyer, H. Li, V. Valentine, V. Kidd, and A. S. Kraft Cloning and Chromosomal Location of a Novel Member of the Myotonic Dystrophy Family of Protein Kinases J. Biol. Chem., April 11, 1997; 272(15): 10013 - 10020. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Al-Shami, S. G. Bourgoin, and P. H. Naccache Granulocyte-Macrophage Colony-Stimulating Factor-Activated Signaling Pathways in Human Neutrophils. I. Tyrosine Phosphorylation-Dependent Stimulation of Phosphatidylinositol 3-Kinase and Inhibition by Phorbol Esters Blood, February 1, 1997; 89(3): 1035 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gonda and R. J. D'Andrea Activating Mutations in Cytokine Receptors: Implications for Receptor Function and Role in Disease Blood, January 15, 1997; 89(2): 355 - 369. [Full Text] [PDF] |
||||
![]() |
T Hara and A Miyajima Function and signal transduction mediated by the interleukin 3 receptor system in hematopoiesis Stem Cells, November 1, 1996; 14(6): 605 - 618. [Abstract] |
||||
![]() |
Y. Zhao, F. Wagner, S. J. Frank, and A. S. Kraft The Amino-terminal Portion of the JAK2 Protein Kinase Is Necessary For Binding and Phosphorylation of the Granulocyte-Macrophage Colony-stimulating Factor Receptor [IMAGE][IMAGE] Chain J. Biol. Chem., June 9, 1995; 270(23): 13814 - 13818. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |